ITA
|
ENG
|
ES
Company
About Us
Partnerships
Download Brochure
All News Releases
Oracle login
Useful Links
Distribution
About us
Regulatory
Products
Storage & Distribution
Marketing
Contact us
Clinical Services
Clinical Research
Regulatory Submissions
Data Management and Statistics
Drug Surveillance
Quality Assurance
Medical Writing
Central Laboratory
Drug Management
Pharmacovigilance Activities
Regulatory Affairs
Meeting and Event Organization
Expertise
Alliances
Contacts
Restricted Access
Sintesi Research, Inc.
1010 N. Central Avenue
Glendale, CA 91202
USA
Sintesi Research S.r.l.
Via Ripamonti 89
20141 Milano - ITALY
Sintesi Research, Spain
Primado Reig 118-3°B
46010 Valencia SPAIN
Sintesi Research, Chile
Augusto Leguia Sur 79, Suite 203, Las Condes Santiago 7550229
CHILE
Sintesi Research, LATAM
BenjamÃn Matienzo 1849 Piso 10 Depto. F, CP
1426 Buenos Aires - ARGENTINA
Sintesi Research, Israel
66 Weitzman St.
Holon
On time, On budget, Full transparency
Sintesi Research is a
Clinical Research Organization
specialized in
Clinical Trials Management
which offers full support in planning, running and reporting Phase I-IV Clinical Trials.
Sintesi Research provides a wide range of professional services and technological solutions to pharmaceutical and biotechnology industries.
Registration, Distribution & Marketing
SINTESI RESEARCH is well placed to act as a distributor for third-party niche and specialty pharmaceutical products, Medical Device, Food Supplement, Drugs, Cosmetics.
news | Highlights
Trial UGA2014-01
A randomized, multicenter, double blind clinical trial comparing pharmacodynamic, pharmacokinetic and safety of a biosimilar Eptacog Alfa (Aryoseven) and Novoseven
®
, in patients wi...
Trial UGA2014-02
Sintesi Research involved in the trial UGA-02. A randomized, multicenter, single dose, cross-over, double blind study comparing the pharmacokinetic of biosimilar Eptacog Alfa with Novoseven®, in p...
3WINTERS-IPS hematology study
Sintesi Research is managing the 3WINTERS-IPS hematology study, whose second phase focused on the 2-year observation of the largest cohort of centrally-confirmed Type 3 Von Willebrand Disease patients...
SIPPET STUDY MAY 2016
We hereby inform you about the published results for the SIPPET trial in the NEJM where SINTESI RESEARCH S.r.l is mentioned as the referred CRO that handled this trial.
ALL NEWS RELEASES
